Cleared Traditional

K842239 - VENTRESCREEN STREP A TEST

K842239 is the FDA 510(k) clearance for VENTRESCREEN STREP A TEST by Ventrex Laboratories, Inc.. It is a Class 1 Microbiology device (product code GWC) cleared through the Traditional 510(k) pathway after a 27-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1984
Decision
27d
Days
Class 1
Risk

K842239 is an FDA 510(k) clearance for the VENTRESCREEN STREP A TEST. Classified as Antisera, All Types, Streptococcus Pneumoniae (product code GWC), Class I - General Controls.

Submitted by Ventrex Laboratories, Inc. (Walker, US). The FDA issued a Cleared decision on July 2, 1984 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ventrex Laboratories, Inc. devices

Submission Details

510(k) Number K842239 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 05, 1984
Decision Date July 02, 1984
Days to Decision 27 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
75d faster than avg
Panel avg: 102d · This submission: 27d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GWC Antisera, All Types, Streptococcus Pneumoniae
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GWC Antisera, All Types, Streptococcus Pneumoniae

Devices cleared under the same product code (GWC) and FDA review panel - the closest regulatory comparables to K842239.
BACTIGEN(R) MENINGITIDIS PANEL
K884965 · Armkel, LLC · Feb 1989
BACTIGEN(R) S. PNEUMONIAE
K884966 · Armkel, LLC · Feb 1989
LKB ULTROBACT (TM) PNEUMOCOCCUS KIT
K862848 · Lkb Instruments, Inc. · Dec 1986
BACTIGEN S. PNEUMONIAE
K831887 · Armkel, LLC · Sep 1983
BBL PNEUMOSLIDE TEST
K821960 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jul 1982
PHADEBACT PNEUMOCOCCUS TEST
K802337 · Pharmacia, Inc. · Oct 1980